Kendall Capital Management boosted its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 29.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,799 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,795 shares […]